A carregar...
Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
Inhibition of epidermal growth factor receptor (EGFR) has become an important target in the treatment of advanced non-small cell lung cancer (NSCLC). Erlotinib and gefitinib, two small molecular agents that target the tyrosine kinase domain of the EGFR, were approved in many countries for the treatm...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3244201/ https://ncbi.nlm.nih.gov/pubmed/22229045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011427927 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|